CLEVELAND, May 13, 2014 /PRNewswire/ -- DATATRAK International, Inc. (DTRK), the leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced that its Chairman and CEO, Mr. Laurence P. Birch, will present at the Drexel Hamilton Micro-Cap Investor Forum on Thursday, May 15th at 3:00 p.m. ET, in New York City.
"DATATRAK has exciting news to share with the investor community," said Mr. Birch. "Our unified eClinical® solutions deliver a differentiated benefit to the clinical trials industry. The DATATRAK ONE® unified platform reduces complexities, delivering time and cost savings and a superior user experience, all of which lead to better site compliance, better data, and ultimately a safer trial. And only DATATRAK offers the unified experience – which is great news for customers and investors alike."
The DATATRAK ONE® platform is the technical infrastructure that powers all DATATRAK products, which can be used in any combination. The inherent strength of DATATRAK solution is the connectivity to the platform, providing a single data source, a single sign-on and a single and user-friendly interface, greatly reducing clinical trial complexities.
Join DATATRAK Thought Leaders:
Tweet: DATATRAK #unifiedexperience to be presented at upcoming investor forum http://bit.ly/1mT3HpB
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. DATATRAK has established a UK entity to support our burgeoning European sales activities; DATATRAK Technologies Limited is a private limited company registered in England and Wales under number 8870946, registered office: One New Change, London, EC4M 9AF, England. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 14, 2014 announcing its results for the full-year period ending December 31, 2013. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.